Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pleyris vs Crinone for Luteal Phase Supplementation in Endometriosis
NCT02793908Phase 3Unknown
- Sponsor
- University of Magna Graecia
- Start
- Jun 2016
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of Luteon in endometriosis (2 arms), sponsored by University of Magna Graecia. Primary endpoint: Change in Visual Analogue Scale for pain. Status: unknown.
02
Drugs
Luteon
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT02793908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02793908.